Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Net Income towards Common Stockholders (2016 - 2026)

Collegium Pharmaceutical has reported Net Income towards Common Stockholders over the past 10 years, most recently at $17.0 million for Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders rose 35.31% year-over-year to $17.0 million; the TTM value through Dec 2025 reached $62.9 million, down 9.13%, while the annual FY2025 figure was $62.9 million, 9.13% down from the prior year.
  • Net Income towards Common Stockholders for Q4 2025 was $17.0 million at Collegium Pharmaceutical, down from $31.5 million in the prior quarter.
  • Over five years, Net Income towards Common Stockholders peaked at $74.0 million in Q2 2021 and troughed at -$25.0 million in Q4 2021.
  • A 5-year average of $11.5 million and a median of $12.3 million in 2024 define the central range for Net Income towards Common Stockholders.
  • Biggest five-year swings in Net Income towards Common Stockholders: plummeted 459.79% in 2021 and later skyrocketed 4415.1% in 2023.
  • Year by year, Net Income towards Common Stockholders stood at -$25.0 million in 2021, then soared by 71.24% to -$7.2 million in 2022, then surged by 543.67% to $31.9 million in 2023, then plummeted by 60.75% to $12.5 million in 2024, then skyrocketed by 35.31% to $17.0 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for COLL at $17.0 million in Q4 2025, $31.5 million in Q3 2025, and $12.0 million in Q2 2025.